Dan Streja

1.8k total citations
34 papers, 794 citations indexed

About

Dan Streja is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Dan Streja has authored 34 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Dan Streja's work include Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Lipoproteins and Cardiovascular Health (8 papers) and Diabetes Management and Research (7 papers). Dan Streja is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Lipoproteins and Cardiovascular Health (8 papers) and Diabetes Management and Research (7 papers). Dan Streja collaborates with scholars based in United States, Canada and Romania. Dan Streja's co-authors include Simon W. Rabkin, George Steiner, Peter O. Kwiterovich, Errol B. Marliss, Elani Streja, M. Vranić, E. B. Marliss, Csaba P. Kövesdy, Hamid Moradi and Moti L. Kashyap and has published in prestigious journals such as JAMA, Annals of Internal Medicine and American Journal of Clinical Nutrition.

In The Last Decade

Dan Streja

32 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Streja United States 15 378 195 189 157 143 34 794
H.C.R. Simpson United Kingdom 12 382 1.0× 240 1.2× 194 1.0× 81 0.5× 97 0.7× 15 1.0k
E J Mayer United States 8 549 1.5× 124 0.6× 222 1.2× 245 1.6× 134 0.9× 8 850
John A. Seibel United States 6 507 1.3× 99 0.5× 234 1.2× 88 0.6× 129 0.9× 7 950
Muñóz United States 7 225 0.6× 138 0.7× 145 0.8× 129 0.8× 126 0.9× 22 743
Mafauzy Mohamed Malaysia 17 610 1.6× 209 1.1× 103 0.5× 153 1.0× 91 0.6× 54 954
Santica Marcovina United States 14 615 1.6× 168 0.9× 331 1.8× 106 0.7× 128 0.9× 29 1.0k
Steven M. Haffner United States 13 618 1.6× 218 1.1× 106 0.6× 183 1.2× 181 1.3× 16 1.1k
Mark Holdbrook United States 14 337 0.9× 121 0.6× 173 0.9× 108 0.7× 200 1.4× 28 909
Elizabeth J Mayer United States 10 516 1.4× 286 1.5× 105 0.6× 316 2.0× 203 1.4× 10 1.2k
Ved V. Gossain United States 18 414 1.1× 121 0.6× 128 0.7× 87 0.6× 116 0.8× 65 868

Countries citing papers authored by Dan Streja

Since Specialization
Citations

This map shows the geographic impact of Dan Streja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Streja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Streja more than expected).

Fields of papers citing papers by Dan Streja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Streja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Streja. The network helps show where Dan Streja may publish in the future.

Co-authorship network of co-authors of Dan Streja

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Streja. A scholar is included among the top collaborators of Dan Streja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Streja. Dan Streja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Streja, Elani, Dan Streja, Melissa Soohoo, et al.. (2018). Precision Medicine and Personalized Management of Lipoprotein and Lipid Disorders in Chronic and End-Stage Kidney Disease. Seminars in Nephrology. 38(4). 369–382. 5 indexed citations
2.
Ahmadi, Seyed‐Foad, Elani Streja, Golara Zahmatkesh, et al.. (2015). Reverse Epidemiology of Traditional Cardiovascular Risk Factors in the Geriatric Population. Journal of the American Medical Directors Association. 16(11). 933–939. 85 indexed citations
3.
Streja, Elani, Csaba P. Kövesdy, Dan Streja, et al.. (2015). Niacin and Progression of CKD. American Journal of Kidney Diseases. 65(5). 785–798. 29 indexed citations
4.
Streja, Dan. (2015). Hypertriglyceridemic Pancreatitis (HTGP). 1 indexed citations
5.
Streja, Dan & Elani Streja. (2014). Management of Dyslipidemia in the Elderly. 1 indexed citations
6.
Streja, Dan. (2008). Optimizing diabetes management through glucose profiling: A case-based approach. Primary care diabetes. 2(4). 167–173. 1 indexed citations
7.
Fernández, Margarita, Minaya Villasana, & Dan Streja. (2006). Glucose dynamics in Type I diabetes: Insights from the classic and linear minimal models. Computers in Biology and Medicine. 37(5). 611–627. 9 indexed citations
8.
Streja, Dan. (2005). Can Continuous Glucose Monitoring Provide Objective Documentation of Hypoglycemia Unawareness?. Endocrine Practice. 11(2). 83–90. 14 indexed citations
9.
Morris, Hedley, B. J. O’Reilly, & Dan Streja. (2005). A new biphasic minimal model. PubMed. 3. 782–785. 3 indexed citations
10.
Fernández, Margarita, Dionisio Acosta, Minaya Villasana, & Dan Streja. (2005). Enhancing parameter precision and the minimal modeling approach in type I diabetes. PubMed. 3. 797–800. 4 indexed citations
11.
Streja, Dan. (2004). Metabolic syndrome and other factors associated with increased risk of diabetes. Clinical cornerstone. 6(3). S14–S29. 9 indexed citations
12.
Streja, Dan, et al.. (2003). Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus. Journal of Diabetes and its Complications. 17(3). 120–127. 53 indexed citations
13.
Streja, Dan & Simon W. Rabkin. (1999). Factors Associated With Implementation of Preventive Care Measures in Patients With Diabetes Mellitus. Archives of Internal Medicine. 159(3). 294–294. 74 indexed citations
14.
Streja, Dan, et al.. (1999). Selective contracting and patient outcomes: a case study of formulary restrictions for selective serotonin reuptake inhibitor antidepressants.. PubMed. 5(9). 1133–42. 23 indexed citations
15.
Rabkin, Simon W., et al.. (1983). Changes in High Density Lipoprotein Cholesterol after Initiation of Insulin Therapy in Non-Insulin Dependent Diabetes Mellitus: Relationship to Changes in Body Weight. The American Journal of the Medical Sciences. 285(3). 14–20. 16 indexed citations
17.
Streja, Dan, et al.. (1980). Changes in plasma high-density lipoprotein cholesterol concentration after weight reduction in grossly obese subjects.. BMJ. 281(6243). 770–772. 41 indexed citations
18.
Streja, Dan. (1979). Triglyceride removal from very low density lipoproteins in vivo as a function of their triglyceride content. Atherosclerosis. 32(1). 57–67. 16 indexed citations
19.
Streja, Dan, George Steiner, E. B. Marliss, & M. Vranić. (1977). Turnover and recycling of glucose in man during prolonged fasting. Metabolism. 26(10). 1089–1098. 54 indexed citations
20.
Streja, Dan. (1975). Fifty-Year Survival After Surgery for Craniopharyngioma. JAMA. 234(5). 510–510. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026